November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Spinal Cord Stimulation Effective for Chronic Pain

Conexiant

November 19, 2024

MASLD Affects 42% of US Adults, Study Finds

A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.

Conexiant

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Processed Diets Linked to Reduced Sperm Quality

Each 10% increase in ultra-processed food intake is linked to a 1.5 million sperm reduction—could substituting whole foods improve outcomes?

Conexiant

November 18, 2024

Leptin's Role in Energy Deficiency Syndromes

Conexiant

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

Conexiant

November 18, 2024

Diabetes Drug Cuts Asthma Attacks By 30%

Adding GLP-1 receptor agonists to metformin therapy may reduce asthma attacks.

Conexiant